Publication | Closed Access
Assessment of health-related quality of life (HRQoL) in KEYNOTE-010: A phase 2/3 study of pembrolizumab vs docetaxel in patients with previously treated advanced NSCLC
11
Citations
0
References
2016
Year
Quality Of LifeAdvanced NsclcLife AssessmentHealth-related QualityClinical TrialsPatient-reported OutcomePharmacotherapyPembrolizumab Vs DocetaxelMedicinePatient SatisfactionHealth Sciences
No additional data available for this publication yet. Check back later!